Exhibit 31.1

  Certification of Principal Executive Officer and Principal Financial Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
             and Securities and Exchange Commission Release 34-46427

I, Anna Kazanchyan, M.D., certify that:

1.  I  have   reviewed  this   quarterly   report  on  Form  10-QSB  of  Heratsi
Pharmaceuticals, Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for  establishing  and maintaining  disclosure  controls and
procedures  (as defined in Exchange Act Rules  13a-15(e) and  15d-15(e)) for the
registrant and we have:

      a)  designed  such  disclosure  controls  and  procedures  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

      b) evaluated the effectiveness of the small business  issuer's  disclosure
controls and procedures and presented in this report our  conclusions  about the
effectiveness  of the disclosure  controls and procedures,  as of the end of the
period covered by this report based on such evaluation;

      c) disclosed in this report any change in  registrant's  internal  control
over financial reporting the occurred during the registrant's most recent fiscal
quarter that has  materially  affected,  or is  reasonably  likely to materially
affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over
financial  reporting,  to the  registrant's  auditors and the audit committee of
registrant's   board  of  directors  (or  persons   performing   the  equivalent
functions):

      a) all deficiencies and material  weaknesses in the design or operation of
internal  control  over  financial  reporting  which  are  reasonably  likely to
adversely  affect the  registrant's  ability to record,  process,  summarize and
report financial information; and

      b) any fraud,  whether or not material,  that involves management or other
employees who have a significant role in the registrant's  internal control over
financial reporting.


Date: September 7, 2006                 /s/ Anna Kazanchyan, M.D.
                                        ----------------------------------------
                                        Anna Kazanchyan, M.D.
                                        Principal Executive Officer
                                        Principal Financial Officer